developer of a blood test that can detect cancer
Dxcover has raised €11M across 2 funding rounds from 11 investors, most recently a round in Feb 2025. Based in Glasgow, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-02-03 | Other | — | Existing investors,Macmillan Cancer Support,Maven Capital Partners | View deal → |
| 2023-02-01 | Series A | €11M | Eos Advisory,European Innovation Council (EIC),Mark Bamforth,Mercia Asset Management,Norcliffe Capital,Scottish Enterprise+2 more | View deal → |
